Procurement in the UKs National Health Service (NHS) is facing its most significant financial challenge. Despite the sheer scale and complexities of the public healthcare sector, the Government's solutions are all too often packaged as "collaborate more", "standardise products" and "leverage spend". Unfortunately, these over simplistic solutions take a myopic view of market drivers, conflate spend with potential savings and fail to deliver value. Many contracts have already been commercially optimised yet the funding crisis continues to deepen. New value-based procurement approaches are needed to drive longer-term innovation and cost reduction and to move debates from efficiencies to embrace effectiveness in integrated supply chains. In thi...
Background: In 2016 the UK Department of Health and Social Care published the results of a comprehen...
In 2008/09, the public sector spent £220 billion on goods and services alone, accounting for one thi...
Public procurement in the medical device sector is complex; it is characterised by dynamism, innova...
Procurement in the UKs National Health Service (NHS) is facing its most significant financial challe...
Procurement in the UKs National Health Service (NHS) is facing its most significant financial challe...
This study reports initial insights on procurement practices across four Healthcare Trusts in the UK...
COVID-19 has thrown NHS procurement into the limelight, but the shortage of personal protective equi...
Background: This review provides intelligence to NHS managers and clinicians involved in commissioni...
COVID-19 has thrown NHS procurement into the limelight, but the shortage of personal protective equi...
Healthcare performances have been for long evaluated according to outcomes and costs. What still nee...
Current English health policy is focused on strengthening the 'demand-side' of the health care syste...
This chapter focuses on the introduction and implementation of the Health and Social Care Act (2012)...
Tony Blair has described investment in the National Health Service as "genuine opportunity to rebuil...
Procurement within the NHS is attracting increasing research and policy interest. However, most of t...
Recent research has highlighted the existence of important differences between public and private se...
Background: In 2016 the UK Department of Health and Social Care published the results of a comprehen...
In 2008/09, the public sector spent £220 billion on goods and services alone, accounting for one thi...
Public procurement in the medical device sector is complex; it is characterised by dynamism, innova...
Procurement in the UKs National Health Service (NHS) is facing its most significant financial challe...
Procurement in the UKs National Health Service (NHS) is facing its most significant financial challe...
This study reports initial insights on procurement practices across four Healthcare Trusts in the UK...
COVID-19 has thrown NHS procurement into the limelight, but the shortage of personal protective equi...
Background: This review provides intelligence to NHS managers and clinicians involved in commissioni...
COVID-19 has thrown NHS procurement into the limelight, but the shortage of personal protective equi...
Healthcare performances have been for long evaluated according to outcomes and costs. What still nee...
Current English health policy is focused on strengthening the 'demand-side' of the health care syste...
This chapter focuses on the introduction and implementation of the Health and Social Care Act (2012)...
Tony Blair has described investment in the National Health Service as "genuine opportunity to rebuil...
Procurement within the NHS is attracting increasing research and policy interest. However, most of t...
Recent research has highlighted the existence of important differences between public and private se...
Background: In 2016 the UK Department of Health and Social Care published the results of a comprehen...
In 2008/09, the public sector spent £220 billion on goods and services alone, accounting for one thi...
Public procurement in the medical device sector is complex; it is characterised by dynamism, innova...